Interview with PrecisionLife

We meet Dr Steve Gardner, Co-Founder of PrecisionLife who are using big data to identify why some drug therapies are more effective on patients than others and how their technology can help predict whether a patient is more likely to be severely affected by a diseases (or indeed the Covid-19 virus) than others.

We hear how the company has seen significant global expansion, was built to scale from the start and he gives 3 useful tips for business founders.